preclinical trial


Also found in: Thesaurus, Wikipedia.
Related to preclinical trial: preclinical study
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.preclinical trial - a laboratory test of a new drug or a new invasive medical device on animal subjects; conducted to gather evidence justifying a clinical trial
trial, run, test - the act of testing something; "in the experimental trials the amount of carbon was measured separately"; "he called each flip of the coin a new trial"
References in periodicals archive ?
NESS ZION A, Israel, June 19, 2014 -- Israeli biotechnology company Kadimastem (TASE: KDST) reported success in a preclinical trial for the treatment of ALS, a group of degenerative diseases that damage the motor neurons that control most of the muscles in the body.
Novavax Inc (Columbia MD) said data from a preclinical trial showed very low doses of its avian flu vaccine still prevented the virus from infecting tested ferrets.
Preclinical trials indicate that the bispecific antibody may exhibit multiple mechanisms of action.
Going forward, Oncolys Biopharma plans to conduct preclinical trials and begin phase I and II clinical trials that target HIV/AIDS patients with resistance to HAART (Highly Active Anti-Retroviral Therapy) by 2008.
The company says in preclinical trials, Provacel reversed the damage caused by heart attack and significantly improved cardiac function.
We have seen encouraging results from the preclinical trials on the use of PG490- 88Na for the treatment of cancer," said Dr.
The models may be credentialed with new agents through systematic preclinical trials to discover how well the mice mimic either the clinical course of human cancer in response to therapy or the development of resistance in response to therapy.
Called Glial Cell Line-Derived Neurotrophic Factor, or GDNF, the drug has been shown to reverse Parkinson's disease symptoms in preclinical trials.
PETACH TIKVA, Israel -- Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, announced today the successful completion of preclinical trials with CF102, the second molecule in the Company's development pipeline, which is the basis for a drug indicated for the treatment of liver cancer and hepatitis.